Nathan Fox, MD

Clinical Focus

• Amniocentesis
• Cesarean Birth
• Endoscopic Ultrasonography
• Fetal Blood Transfusion
• Gestational Diabetes
• Miscarriage
• Placenta Previa
• Pre-Eclampsia
• Premature Birth

• Amniocentesis
• Cesarean Birth
• Endoscopic Ultrasonography
• Fetal Blood Transfusion
• Gestational Diabetes
• Miscarriage
• Placenta Previa
• Pre-Eclampsia
• Premature Birth

Locations

Maternal Fetal Medicine Associates, PLLC

Maternal Fetal Medicine Associates, PLLC, 70 East 90th Street, New York, NY, 10021

212-722-7409

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:28

Article:148

Review Article:10

Comment/Debate:6

Letter:14

Editorial:1

Recent Artifacts

• Should twin-specific growth charts be used to assess fetal growth in twin pregnancies?
• Trial of labor of vertex-nonvertex twins following a previous cesarean delivery
• Incidence and Risk Factors for a Malpositioned Intrauterine Device Detected on Three-Dimensional Ultrasound Within Eight Weeks of Placement
• Optimal gestational age for cervical length in twins: still an open debate!
• Prevention of preterm birth in twin pregnancies
• Screening for preterm birth in twin pregnancies
• Stratified risk of pregnancy loss for women with a viable singleton pregnancy in the first trimester
• The association between sonographic cervical length components and preterm birth in women with ultrasound- or exam-indicated cerclage
• Elective fetal reduction by radiofrequency ablation in monochorionic diamniotic twins decreases adverse outcomes compared to ongoing monochorionic diamniotic twins
• Respiratory and glycemic control outcomes of late preterm infants after antenatal corticosteroid exposure

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Fox during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.